Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 13, 2020

SELL
$2.15 - $4.41 $21,500 - $44,100
-10,000 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$4.09 - $7.19 $76,483 - $134,453
-18,700 Reduced 65.16%
10,000 $69,000
Q3 2018

Nov 14, 2018

BUY
$5.68 - $8.59 $24,747 - $37,426
4,357 Added 17.9%
28,700 $182,000
Q2 2018

Aug 14, 2018

BUY
$7.16 - $10.05 $101,263 - $142,137
14,143 Added 138.66%
24,343 $184,000
Q1 2018

May 14, 2018

BUY
$7.95 - $11.65 $81,090 - $118,830
10,200 New
10,200 $82,000

Others Institutions Holding ALPN

About ALPINE IMMUNE SCIENCES, INC.


  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.